Innovative Strategies in Overcoming Antimicrobial Resistance: From Phage Therapy to Combination
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Microbiology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 4
Special Issue Editor
Interests: host-pathogen interactions; antimicrobial resistance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bacteriophages (phages) are viruses that infect, replicate within, and kill bacteria, offering immense potential as a powerful tool in combating antibiotic resistance. There is renewed interest in phage therapy as many bacterial infections are becoming resistant to antibiotics, leaving us with fewer effective treatment options. The killing mechanism of phages differs from that of antibiotics and holds great promise not only in treating infections but also in preventing their spread and minimizing the emergence of antibiotic resistance.
In the following Special Issue “Innovative Strategies in Overcoming Antimicrobial Resistance: From Phage Therapy to Combination”, we invite your original cutting-edge research (research articles and reviews) that have the potential to contribute to our understanding of phage therapy. The topics covered in this Special Issue include, but are not limited to, the following:
- Novel phage discovery
- Basic phage therapy
- Phage engineering
- Phage +/- antibiotic therapy
- Phage pharmacokinetics
Dr. Rajnikant Sharma
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bacteriophages
- phage therapy
- antimicrobial resistance
- phage engineering
- phage-antibiotic combination
- phage pharmacokinetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
